Endoscopic Metabolic and Bariatric Therapies
Public ClinicalTrials.gov record NCT05725967. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective collection of data from adult patients who have had an endoscopic metabolic and bariatric endoscopy procedure (EMBT) for primary or revision surgical procedures for obesity.
Study identification
- NCT ID
- NCT05725967
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 5,000 participants
Conditions and interventions
Conditions
- Obesity
- Obesity, Morbid
- Obesity Associated Disorder
- Bariatric Surgery Candidate
- Fistula, Gastric
- Roux-en-y Anastomosis Site
- Ulcer, Gastric
- Abdominal Pain
- Abdominal Obesity
- Complication of Surgical Procedure
- Complication of Treatment
- Complication,Postoperative
- Weight Gain
- Weight Loss
- Leak, Anastomotic
- Delayed Gastric Emptying Following Procedure
Interventions
- Primary Obesity Endoscopic Procedures Procedure
- Endoscopic Revision of Bariatric Surgical Procedures Procedure
- Bariatric Surgery Procedures Procedure
- Endoscopic Sleeve Gastroplasty, Trans-oral Outlet Reduction Device
- Intragastric Balloon Device
- Primary obesity surgery endoluminal, Restorative obesity surgery endoluminal Device
- Argon Plasma Coagulation, Gastroplasty with Endoscopic Myotomy, Bariatric Endoscopic Antral Myotomy, Pylorus Sparing Antral Myotomy Device
- Aspiration Therapy Device
Procedure · Device
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2022
- Primary completion
- May 27, 2028
- Completion
- May 27, 2029
- Last update posted
- Dec 1, 2025
2022 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05725967, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05725967 live on ClinicalTrials.gov.